NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-OD-21-025 from the NIH Guide for Grants and Contracts
Notice NOT-DA-20-096 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-21-036 from the NIH Guide for Grants and Contracts. NIAMS Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
Notice NOT-NR-20-007 from the NIH Guide for Grants and Contracts
Notice NOT-DA-21-010 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-21-033 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to seek research projects that implement early phase (Phase 0, I, and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research mission of the National Cancer Institute's (NCI) Division of Cancer Treatment and Diagnosis (DCTD). Applicants are strongly encouraged to consult the NCI DCTD website at https://dctd.cancer.gov/ to learn more about the various program goals, research priorities, and strategies developed to fight cancer. Applications submitted to this FOA must include studies that meet the National Institutes of Health (NIH) definition of a clinical trial (see NOT-OD-15-015 for details) and provide specific clinical trial information as described in this FOA. Applications that propose phase III clinical trials in any area of cancer research are not sought by and will not be supported through this FOA.
Notice NOT-RM-21-008 from the NIH Guide for Grants and Contracts
Notice NOT-RM-21-007 from the NIH Guide for Grants and Contracts
Notice NOT-RM-21-006 from the NIH Guide for Grants and Contracts
Notice NOT-RM-21-002 from the NIH Guide for Grants and Contracts
Notice NOT-RM-21-003 from the NIH Guide for Grants and Contracts
Notice NOT-RM-21-001 from the NIH Guide for Grants and Contracts
Notice NOT-EB-20-022 from the NIH Guide for Grants and Contracts
Notice NOT-AI-21-002 from the NIH Guide for Grants and Contracts
Notice NOT-HD-20-037 from the NIH Guide for Grants and Contracts
Notice NOT-DA-21-005 from the NIH Guide for Grants and Contracts
Notice NOT-DK-21-002 from the NIH Guide for Grants and Contracts
Notice NOT-CA-21-014 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-21-035 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications for support of investigator-initiated clinical trials that have the potential to reduce the burden of cancer through improvements in early detection, screening, prevention and interception, healthcare delivery, quality of life, and/or survivorship related to cancer; with such attributes, the proposed studies should also have the potential to improve clinical practice and/or public health. Applications submitted to this FOA must include studies that meet the National Institutes of Health (NIH) definition of a clinical trial (see NOT-OD-15-015 for details) and provide specific clinical trial information as described in this FOA. This FOA does not and will not support clinical trials for studies of cancer diagnosis and/or oncologic therapy in patients. The proposed investigator-initiated projects should be related to the programmatic interests of the NCI Division of Cancer Prevention and/or the NCI Division of Cancer Control and Population Sciences.
Notice NOT-AG-20-055 from the NIH Guide for Grants and Contracts